文献速递中毒与环境急症消化、代谢与肾脏急症

高风险急诊物质相关就诊患者过量死亡预测因素:数据链接队列研究

Predictors of Overdose Death Among High-Risk Emergency Department Patients With Substance-Related Encounters: A Data Linkage Cohort Study.
PubMed 文献 · Ann Emerg Med · 2019-09-09
一句话结论急诊物质相关就诊成人中,同时合并阿片类与其他物质使用障碍、既往≥3次非致命性过量或既往海洛因过量者,后续阿片类过量死亡风险最高。

该回顾性队列研究将马里兰州2014至2015年成人非致命性过量或物质使用障碍的急诊住院索赔记录,与2015至2016年法医死亡记录链接。共139,252例物质相关急诊就诊患者,其中963例后续发生阿片类过量死亡,病死率为每10,000例患者69.2例,为因任何原因使用急诊患者的6倍。与死亡最强相关的因素包括同时合并阿片类和其他物质使用障碍(调整比值比2.88;95%CI 2.04至4.07)、既往≥3次非致命性过量(调整比值比2.89;95%CI 1.54至5.43)及既往海洛因相关非致命性过量(调整比值比2.24;95%CI 1.64至3.05)。作者认为常规病历数据可能有助于评估未来不良结局风险并识别启动和连接救命照护的主要目标。

要点

  • 139,252例物质相关急诊就诊患者中963例后续发生阿片类过量死亡,病死率每10,000例患者69.2例,为因任何原因使用急诊患者的6倍。
  • 同时合并阿片类和其他物质使用障碍者后续阿片类过量死亡风险最高(调整比值比2.88;95%CI 2.04至4.07)。
  • 既往≥3次非致命性过量者后续阿片类过量死亡风险升高(调整比值比2.89;95%CI 1.54至5.43)。
  • 既往海洛因相关非致命性过量者后续阿片类过量死亡风险升高(调整比值比2.24;95%CI 1.64至3.05)。
  • 作者认为常规病历数据可能有助于评估未来不良结局风险并识别启动和连接救命照护的主要目标。

适用人群与场景

  • 2014至2015年在马里兰州急诊就诊、有非致命性过量或物质使用障碍相关就诊记录的成人。

研究设计与关键结果

  • 研究设计为回顾性队列研究,将马里兰州2014至2015年成人非致命性过量或物质使用障碍急诊住院索赔记录与2015至2016年法医死亡记录链接。
  • 共139,252例患者有物质相关急诊就诊,其中963例后续发生阿片类过量死亡,病死率为每10,000例患者69.2例,为因任何原因使用急诊患者的6倍。
  • 同时合并阿片类和其他物质使用障碍与后续阿片类过量死亡相关(调整比值比2.88;95%CI 2.04至4.07)。
  • 既往≥3次非致命性过量与后续阿片类过量死亡相关(调整比值比2.89;95%CI 1.54至5.43)。
  • 既往海洛因相关非致命性过量与后续阿片类过量死亡相关(调整比值比2.24;95%CI 1.64至3.05)。
  • 作者计算了具有不同过量和物质使用诊断史组合的假设患者的过量死亡预测概率。

证据类型、等级与局限

  • 证据类型:回顾性队列研究(数据链接)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,这些结果凸显了因物质相关状况在急诊接受治疗的患者之间过量风险存在重要差异。
  • 作者认为,研究结果展示了纳入患者病历常规数据以评估未来不良结局风险并识别启动和连接救命照护主要目标的潜在效用。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

STUDY OBJECTIVE: Persons with substance use disorders frequently utilize emergency department (ED) services, creating an opportunity for intervention and referral to addiction treatment and harm-reduction services. However, EDs may not have the appropriate tools to distinguish which patients are at greatest risk for negative outcomes. We link hospital ED and medical examiner mortality databases in one state to identify individual-level risk factors associated with overdose death among ED patients with substance-related encounters.

METHODS: This retrospective cohort study linked Maryland statewide ED hospital claims records for adults with nonfatal overdose or substance use disorder encounters in 2014 to 2015 with medical examiner mortality records in 2015 to 2016. Logistic regression was used to identify factors in hospital records associated with risk of opioid overdose death. Predicted probabilities for overdose death were calculated for hypothetical patients with different combinations of overdose and substance use diagnostic histories.

RESULTS: A total of 139,252 patients had substance-related ED encounters in 2014 to 2015. Of these patients, 963 later experienced an opioid overdose death, indicating a case fatality rate of 69.2 per 10,000 patients, 6 times higher than that of patients who used the ED for any cause. Factors most strongly associated with death included having both an opioid and another substance use disorder (adjusted odds ratio 2.88; 95% confidence interval 2.04 to 4.07), having greater than or equal to 3 previous nonfatal overdoses (adjusted odds ratio 2.89; 95% confidence interval 1.54 to 5.43), and having a previous nonfatal overdose involving heroin (adjusted odds ratio 2.24; 95% confidence interval 1.64 to 3.05).

CONCLUSION: These results highlight important differences in overdose risk among patients receiving care in EDs for substance-related conditions. The findings demonstrate the potential utility of incorporating routine data from patient records to assess risk of future negative outcomes and identify primary targets for initiation and linkage to lifesaving care.

来源:Ann Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Krawczyk N, Eisenberg M, Schneider KE, et al. Predictors of Overdose Death Among High-Risk Emergency Department Patients With Substance-Related Encounters: A Data Linkage Cohort Study. Ann Emerg Med. 2019. PMID: 31515181. doi:10.1016/j.annemergmed.2019.07.014

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。